X

See our new webpage about the GA-map® Dysbiosis Test

Visit page

Skip to content

Home
About us
Products
- Service Products
  - The GA-map® Dysbiosis Test Lx
  - The GA-map® COVID-19 Fecal Test Kit
- Lab Products
  - The GA-map® Dysbiosis Lx reagent kit
  - The GA-map® COVID-19 reagent kit
News
- Press Releases
- News
For Investors
Order
Contact us

Home
About us
Products
- Service Products
  - The GA-map® Dysbiosis Test Lx
  - The GA-map® COVID-19 Fecal Test Kit
- Lab Products
  - The GA-map® Dysbiosis Lx reagent kit
  - The GA-map® COVID-19 reagent kit
News
- Press Releases
- News
For Investors
Order
Contact us

genanalysis

Research on gastrointestinal infection on COVID-19

2021-03-242021-01-20

Genetic Analysis AS announces that two patents were granted in Russia and EU, from family WO2016156251A1

2021-07-082020-12-16

Successful share issue and change in the management team

2021-05-192020-08-25

Post navigation

Newer posts

← Previous Page1 Page2

Genetic Analysis AS is providing a CE-marked gut microbiota analysis for testing bacterial imbalance in IBS and IBD patients.

Contact

Phone: +47 48 32 16 10
E-mail: info@genetic-analysis.com
Address: Genetic Analysis AS, Ulvenveien 80B
0581 Oslo, Norway

Open Google Maps

Connect

Navigate

© 2023 Genetic Analysis

Home
About us
Products
- Service Products
  - The GA-map® Dysbiosis Test Lx
  - The GA-map® COVID-19 Fecal Test Kit
- Lab Products
  - The GA-map® Dysbiosis Lx reagent kit
  - The GA-map® COVID-19 reagent kit
News
- Press Releases
- News
For Investors
Order
Contact us